A Case Study on the Breast Cancer Patients Using Ortho-Cellular Nutrition Therapy (OCNT)

Jang Ji-Youn (장지연)

A Case Study on the Breast Cancer Patients Using Ortho-Cellular Nutrition Therapy (OCNT)

CELLMED
Abbr : CellMed
2023, 13(11), pp.1~5
Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
Research Area : Medicine and Pharmacy > General Medicine
Received : August 30, 2023
Accepted : August 30, 2023
Published : August 31, 2023

Jang Ji-Youn ¹

¹이화약국

Irregular Papers

ABSTRACT

Objective: Case report of improvement in muscle pain, insomnia, and depression in a breast cancer patient using Ortho-Cellular Nutrition Therapy. Methods: A Korean woman in her 50s was diagnosed with breast cancer. After being diagnosed with stage 1 breast cancer, her quality of life has greatly deteriorated due to the side effects of the drugs administered. Results: Symptoms of insomnia and muscle pain improved after nutritional therapy. Conclusion: Applying nutritional therapy to patients with the aforementioned condition can help alleviate symptoms.

KEYWORDS

Ortho-Cellular Nutrition Therapy (OCNT), breast cancer, improved adverse drug reaction, muscle pain, insomnia, depression

Journal Copyright Policy

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Citation status

* References for papers published after 2025 are currently being built.

[journal] Ahmed, M / 2014 / The management of screen-detected breast cancer / Anticancer Res 34 : 1141~1146

[journal] Geniey Yang / 2013 / Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs / Pharmacology & Therapeutics / Elsevier BV 139(3) : 392~404

[journal] Riggs, B. L. / 2003 / Selective estrogen-receptor modulators—mechanisms of action and application to clinical practice / J. N. E. J. o. M 348 : 618~629

[journal] Partridge, A. H / 2003 / Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer / J. o. C. O 21 : 602~606

[journal] Goldenberg, D. L / 2004 / Management of fibromyalgia syndrome / J. J 292 : 2388~2395

[journal] Breyer‐Pfaff, U. / 2004 / The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man / J. D. m. r 36 : 723~746

[journal] Wang, B. / 2009 / New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme / Drug Metab Rev 41 : 573~643

[journal] Wang, X / 2014 / The endogenous substrates of brain CYP2D / J. E. j. o. p 724 : 211~218

[journal] Anderson, B. M / 2009 / Are all n-3 polyunsaturated fatty acids created equal? / J. L. i. h. & Disease 8 : 1~20

[journal] Guesnet, P. / 2011 / Docosahexaenoic acid (DHA) and the developing central nervous system (CNS)–implications for dietary recommendations / J. B 93 : 7~12

[journal] Spector, A. A. / 2015 / Discovery of essential fatty acids / J. J. o. l. r 56 : 11~21

[journal] Spector, A. A. / 1999 / Essentiality of fatty acids / J. L 34 : S1~S3

[journal] Yu, H. / 2022 / Dietary chlorella (Chlorella vulgaris) supplementation effectively improves body color, alleviates muscle inflammation and inhibits apoptosis in largemouth bass (Micropterus salmoides) 127 : 140~147

[journal] Dubey, V. K / 2015 / Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats / J. J. o. T. E. i. M. & Biology 29 : 222~226

[journal] Yano, J. M / 2015 / Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis 161 : 264~276

[journal] Coppen, A. / 2005 / Treatment of depression: time to consider folic acid and vitamin B12 / J Psychopharmacol 19 : 59~65

[journal] Kedzierska, M. / 2012 / Effects of the commercial extract of aronia on oxidative stress in blood platelets isolated from breast cancer patients after the surgery and various phases of the chemotherapy 83 : 310~317

KJCKorea
Journal Central

CELLMED 2025 KCI Impact Factor : 0.18